Synthesis, in silico studies and in vitro cytotoxicity evaluation of novel posaconazole derivative as a ALK TK inhibitor-Reference-Cited by-同舟云学术

Synthesis, in silico studies and in vitro cytotoxicity evaluation of novel posaconazole derivative as a ALK TK inhibitor

Published:2024-04-03 Issue:1 Volume:18 Page:
ISSN:1658-3655
Container-title:Journal of Taibah University for Science
language:en
Short-container-title:Journal of Taibah University for Science

Author:

Jawarkar Rahul D.¹,Sharma Praveen¹,Jain Sachin¹,Shah Umang²,Zaki Magdi EA³,Al-Hussain Sami A³,Mali Suraj⁴,Lai Chin-Hung⁵,Masand Vijay H.⁶,Humne Vivek T⁷

Affiliation:

1. Faculty of Pharmacy, Oriental University, Indore, India

2. Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, India

3. Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic university, Riyadh, Saudi Arabia

4. Department of Pharmaceutical Chemistry, School of Pharmacy, D.Y. Patil University (Deemed to be University), Navi Mumbai, India

5. Department of Medical Applied Chemistry, Chung Shan Medical University, Taichung, Taiwan

6. Department of Chemistry, Vidyabharati Mahavidyalaya, Amravati, India

7. Department of Chemistry, Shri R. R. Lahoti Science college, Amravati, India

Funder

Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/16583655.2024.2336674

Reference42 articles.

1. The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020

2. Recent advances in the development of dual ALK/ROS1 inhibitors for non-small cell lung cancer therapy

3. Recent advances in the management of lung cancer

4. Diagnosis and Molecular Classification of Lung Cancer

5. The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Exploration of Naturally Occurring Flavonoids as TGF‐β Inhibitors in Breast Cancer: Insights from Docking and Molecular Dynamics Simulations and In‐vitro Cytotoxicity Study;Chemistry & Biodiversity;2024-05-20